Prosecution Insights
Last updated: April 19, 2026

Kite Pharma Inc.

16 pending office actions

Portfolio Summary

16
Total Pending OAs
5
Final Rejections
11
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
19044010 METHODS AND SYSTEMS FOR SCHEDULING A PATIENT-SPECIFIC IMMUNOTHERAPY PROCEDURE SANGHERA, STEVEN G.S. 3684 Non-Final OA Feb 03, 2025
18496588 FACTORS FOR OPTIMIZING IMMUNOTHERAPY DAUNER, JOSEPH G 1682 Non-Final OA Oct 27, 2023
18455028 IMMUNE CELL FUNCTION ALDARONDO, DASIA ALI 1647 Non-Final OA Aug 24, 2023
18330962 METHODS OF PREPARING LYMPHOCYTES FOR CELL THERAPY ALDARONDO, DASIA ALI 1647 Non-Final OA Jun 07, 2023
18327651 CHIMERIC TRANSMEMBRANE PROTEINS AND USES THEREOF NGUYEN, QUANG 1631 Non-Final OA Jun 01, 2023
18323914 NON-VIRAL DELIVERY OF CELL THERAPY CONSTRUCTS STEIN, LEAH ELIZABETH 1641 Final Rejection May 25, 2023
18175049 ALLOGENEIC THERAPEUTIC CELLS SHUPE, ELIZABETH A 1643 Non-Final OA Feb 27, 2023
18167725 METHODS OF ADMINISTERING CHIMERIC ANTIGEN RECEPTOR IMMUNOTHERAPY OUSPENSKI, ILIA I 1644 Non-Final OA Feb 10, 2023
17816076 MONITORING AND MANAGEMENT OF CELL THERAPY-INDUCED TOXICITIES FRITCHMAN, REBECCA M 1758 Non-Final OA Jul 29, 2022
17814811 SPLIT CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE HECK, BRYAN WILLIAM 1643 Final Rejection Jul 25, 2022
17852918 CLOSED-SYSTEM AND METHOD FOR AUTOLOGOUS AND ALLOGENEIC CELL THERAPY MANUFACTURING SKELDING, ZACHARY S 1644 Non-Final OA Jun 29, 2022
17751586 CHIMERIC RECEPTORS TO FLT3 AND METHODS OF USE THEREOF NATARAJAN, MEERA 1643 Final Rejection May 23, 2022
17774720 CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY JOHANSEN, PETER N. 1644 Non-Final OA May 05, 2022
17679521 METHODS AND SYSTEMS FOR PERFORMING A PATIENT-SPECIFIC IMMUNOTHERAPY PROCEDURE WITH CHAIN-OF-CUSTODY AND CHAIN-OF-IDENTITY BIOLOGICAL SAMPLE TRACKING WANG, RUIXUE 1672 Final Rejection Feb 24, 2022
17675294 IMMUNOTHERAPIES DONOGHUE, BRITTNEY ERIN 1675 Final Rejection Feb 18, 2022
16969127 MODIFIED PLURIPOTENT STEM CELLS AND METHODS OF MAKING AND USE ROGERS, ERIC JASON 1638 Non-Final OA Aug 11, 2020

Managing Kite Pharma Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month